MUC16 and ovarian carcinoma: A prospective multicenter study shown that the risk of ovarian malignancy algorithm based on the CA125 and HE 4 levels can be used to evaluate the risk of epithelial ovarian cancer in premenopausal and postmenopausal women with pelvic masses (40).